Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity

Clinical Trial Grant

Duke Scholars

William Raymond Herzog

Principal Investigator William Raymond Herzog Medicine, Cardiology

Administered By

Institutes and Centers

Awarded By

Novo Nordisk, Inc.

Start Date

May 24, 2019

End Date

July 18, 2024

Administered By

Institutes and Centers

Awarded By

Novo Nordisk, Inc.

Start Date

May 24, 2019

End Date

July 18, 2024